Release date: 7/31/24
Expiration date: 7/30/26
Estimated Time of Completion: 4 hours and 45 minutes
Description
Session Agenda
Update in Treatment of Atopic Dermatitis
Raj Chovatiya, MD, PhD, Rosalind Franklin University Chicago Medical School
Update in Treatment of Inflammatory Alopecias
Melissa Piliang, MD, Cleveland Clinic
Update in Treatment of Chronic Urticaria
James Fernandez, MD, PhD, Cleveland Clinic
Update in Treatment of Hidradenitis Suppurativa
Amit Garg, MD, Hofstra/Northwell
Present State and Future of Medical Dermatology: Insights from Tenures as Editor-in-Chief of the JAAD and AAD President *
Dirk Elston, MD, Medical University of South Carolina
Update in Treatment of Psoriasis Vulgaris
Anthony Fernandez, MD, PhD, Cleveland Clinic
Update in Treatment of Psoriatic Arthritis
M. Elaine Husni, MD, MPH, Cleveland Clinic
Description
Watch Medical Dermatology Therapy Update Webcast Series, recorded from Medical Dermatology Therapy Update III: Autoimmune, Chronic Inflammatory, and Advanced Malignant Diseases.
This CE-certified educational series offers a unique opportunity to update your knowledge and understanding of both traditional and new therapeutic strategies for a range of critically important medical dermatologic conditions, including rheumatology-dermatology overlap diseases, atopic dermatitis, advanced melanoma and other cutaneous malignancies, urticaria, sarcoidosis, hidradenitis suppurativa, autoimmune bullous disease, cutaneous lymphomas, alopecia areata, and psoriatic disease.
Learning Objectives
- Introduce the evolving and controversial concept of remission in atopic dermatitis (AD).
- Review current systemic therapeutic options for atopic dermatitis and understand efficacy data under the potential lens of remission.
- Review the current guidelines and the efficacy of the initial guideline-based treatments for chronic urticaria.
- Discuss current and potential treatment options for severe refractory patients.
- Examine current and future approaches to phenotyping patients and the utilization of laboratory testing in CSU.
- Describe threats to drug development programs in hidradenitis suppurativa (HS).
- Highlight treatment approaches for patients with HS.
- Describe the therapeutic pipeline in HS.
- Review “treat-to-target” goals for psoriasis.
- Describe current psoriasis therapies and progress in achieving “pinnacles” of psoriasis outcomes.
- Identify heterogeneity in psoriatic diseases.
- Recognize recent advances in PsA treatment.
- Discuss treatment management strategies that may influence patient care.
Target Audience
The online series is designed for physicians, pharmacists, nurses, advanced practice clinicians, physician assistants, residents, fellows and allied health professionals in dermatology, immunology, oncology, rheumatology, internal medicine, family medicine, and general practice.
Accreditation
In support of improving patient care, Cleveland Clinic Center for Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians / American Medical Association (AMA)
Cleveland Clinic Foundation Center for Continuing Education designates this internet enduring activity for a maximum of 4.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.
Nurses / American Nurses Credentialing Center (ANCC)
Cleveland Clinic Center for Continuing Education designates this internet enduring activity for a maximum of 4.75 ANCC contact hours.
Physician Assistants / American Academy of PAs (AAPA)
Cleveland Clinic Center for Continuing Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 4.75 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Accreditation Council of Pharmacy Education (ACPE)
Cleveland Clinic Center for Continuing Education designates this knowledge-based activity for a maximum of 4.75 hours. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion.
Universal Activity Number List:
JA0000192-0000-24-547-H01-P
JA0000192-0000-24-547-H01-T
Certificate of Participation
A certificate of participation will be provided to other health care professionals for requesting credits in accordance with their professional boards and/or associations.
Activity Director and Faculty
Activity Director
Anthony P. Fernandez, MD, PhD
Director of Medical Dermatology
Department of Dermatology
Cleveland Clinic
Cleveland, OH
Planning Committee
Madeline June, CNP
Department of Dermatology
Cleveland Clinic
Cleveland, OH
Sean Krohn, PharmD
Specialty Pharmacy
Cleveland Clinic
Cleveland, OH
Jessica Wampleman, RN
Department of Dermatology
Cleveland Clinic
Cleveland, OH
Clara Wilson, PA-C
Department of Dermatology
Cleveland Clinic
Cleveland, OH
Faculty
Raj Chovatiya, MD, PhD
Associate Professor
Rosalind Franklin University Chicago Medical School
Founder and Director, Center for Medical Dermatology and Immunology Research
Chicago, IL
Dirk Elston, MD
Professor and Chair, Department of Dermatology
and Dermatologic Surgery
Medical University of South Carolina
Mount Pleasant, SC
Anthony P. Fernandez, MD, PhD
Director of Medical Dermatology
Department of Dermatology
Cleveland Clinic
Cleveland, OH
James Fernandez, MD, PhD
Department of Allergy and Clinical Immunology
Cleveland Clinic
Cleveland, OH
Amit Garg, MD
Professor and Founding Chair
Department of Dermatology
Zucker School of Medicine
Hofstra/Northwell
New Hyde Park, NY
M. Elaine Husni, MD, MPH
Department of Rheumatic and Immunologic Disease
Cleveland Clinic
Cleveland, OH
Melissa Piliang, MD
Department of Dermatology
Cleveland Clinic
Cleveland, OH
CME Disclaimer
The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.
Disclosures
In accordance with the Standards for Integrity and Independence issued by the Accreditation Council for Continuing Medical Education (ACCME), Cleveland Clinic Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty have indicated that they may have a relationship, which in the context of their presentation(s), could be perceived as a potential conflict of interest:
| Raj Chovatiya, MD |
|
Abbvie Pharmaceuticals, Arcutis, Beiersdorf, Inc., Boehringer Ingelheim, Bristol-Myers Squibb Co., Dermavant Sciences, Inc., Eli Lilly, Incyte, LEO Pharma, Pfizer, Inc., Regeneron, Sanofi, UCB |
Consulting
Teaching and Speaking |
Amgen, Apogee Therapeutics, ArgenX, ASLAN Pharmaceuticals, Cara Therapeutics, Facilitation of Dermatologic Education (FIDE), Galderma, Genentech, GSK, Nektar Pharmaceuticals, RAPT Therapeutics |
Consulting |
Novartis |
Teaching and Speaking |
| Anthony P. Fernandez, MD, PhD |
|
Boehringer Ingelheim
UCB, Inc. |
Consulting |
Bristol-Myers Squibb Co.
Novartis
Mallinckrodt Inc.
Biogen Inc. |
Consulting
Teaching and Speaking |
Pfizer, Inc. |
Other activities from which remuneration is received or expected: awarded a grant to fund a medical dermatology fellowship position
Research: PI |
Abbvie Pharmaceuticals |
Consulting
Advisor or review panel participant
Teaching and Speaking |
Kyowa Kirin |
Teaching and Speaking |
| James Fernandez, MD |
|
Baxalta |
Teaching and Speaking |
| Amit Garg, MD |
|
Abbvie, Boehringer Ingelheim, UCB |
Advisor or review panel participant
Research: PI |
Insmed |
Advisor or review panel participant |
Incyte, Novartis, Union Therapeutics |
Advisor or review panel participant |
| M. Elaine Husni, MD |
|
Abbvie Pharmaceuticals, Amgen, Bristol-Myers Squibb Co., Janssen, Lilly, Regeneron |
Consulting
Advisor or review panel participant |
Novartis Pharmaceuticals |
Consulting
Advisor or review panel participant
Teaching and Speaking |
Pfizer, Inc. |
Advisor or review panel participant |
UCB, Inc. |
Consulting |
National Psoriasis Foundation |
Other activities from which remuneration is received or expected: grant support to the project
Research: PI NPF grant: Mind Matters: A high touch, low cost approach to improving mental health outcomes in patients with Psoriatic Disease |
| Melissa Piliang, MD |
|
Eli Lilly, Pfizer, Inc. |
Consulting
Teaching and Speaking
Research: Co-investigator |
Procter & Gamble |
Consulting
Teaching and Speaking |
The following faculty have indicated they have no relationship which, in the context of their presentation(s), could be perceived as a potential conflict of interest:
Dirk Elston, MD
Madeline June, CNP
Sean Krohn, PharmD
Jessica Wampleman, RN
Clara Wilson, PA-C
Acknowledgment
The Cleveland Clinic Foundation Center for Continuing Education acknowledges educational grants for partial support of this activity from:
Janssen Scientific Affairs, LLC
Novartis Pharmaceuticals Corporation
Sun Pharmaceutical Industries, Inc.
This CME activity was produced by the Cleveland Clinic Foundation Center for Continuing Education, Cleveland Clinic’s Department of Dermatology.
